Globus Medical Inc. advanced stock charts by Barron's. View GMED historical stock data and compare to other stocks, and exchanges.

Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...

Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2025 ...

It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has declined 17% over the past three months. It seems that the market might have completely ...

The Central Drugs Standard Control Organisation (CDSCO) has upgraded its online registration system and has asked all medical device manufacturers to re-submit market standing certificates and non ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $88.00. The company’s shares closed last Friday ...